But here's what I don't understand -- why would the FDA
But here's what I don't understand -- why would the FDA have allowed Leronlimab to be used for 30 or so EIND critically ill patients, if not to hopefully save lives?
_____________
Because the FDA, just any other state agency, must first and foremost cover their behinds. It's a part of the game. Let's suppose the "American public" is something that really exist and even can wage a powerful protest through "free press" which would make TPTB to investigate the FDA's games with CYDY. The agency then will have the irrefutable evidence of its good will, nay, its eagerness to go an extra mile for the sake of the American people. They allowed Leron as many COVID-19 EINDs as were requested. They speedily approved its two clinical studies for COVID-19. They approved a basket cancer trial and gave other similar goodies to NP. They had approved Leron for the HIV combo! And if all this evidence is still not enough for the American public and FBI, listen to each and every public appearance of Mr. Pourhassan in which he showers our agency with endless praises! Of course, none of the above matters at all! For the FDA, as any other state agency, has up its sleeve the endless number of tricks not to allow the commercialization of any drug that they for whatever reason don't want to succeed. On my short memory of following CYDY they used only one of those tricks when out of the blue they told NP to change the clinical part of BLA just "nine days" before it was ready to be submitted. And this little trick alone has cost us already 4 months and counting. Yep, it will be a lengthy uphill struggle with by no means certain results.
1
CytoDyn Inc (CYDY) Stock Research Links
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...
Continue Reading
Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...
Continue Reading
Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...
Continue Reading
Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...
Continue Reading
RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...
Continue Reading
A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...
Continue Reading
Sparking a Fresh Wave in the Kids' Beverage Market Alright, let me tell you about a new player plowing into the kids' drink scene. Wave Kids™, a brand that's making waves—pun intended—has a fresh lineup that screams 'fun' and 'healthy' in equal measure. Just coinciding with back-to-school season, this Scottsdale, Arizona outfit has rolled out not one or two, but...
Continue Reading
AI Signaling Moves Beyond GCW's Own Clients Remember when we first looked at GCW's SignlLabs and the idea of helping brands show up inside ChatGPT, Gemini, Claude, Copilot and Perplexity? Well, Global Communication Works is taking the next step. Instead of keeping its AI Signaling playbook inside the agency walls, GCW is now opening SignlLabs up for licensing
Continue Reading
A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...
Continue Reading
Unpacking Cove Capital's Latest Victory Cove Capital Investments has pulled off another coup, raising a hefty $9,964,510 for its Cove Essential Net Lease Industrial 108 DST. It's a Regulation D, Rule 506(c) offering, now fully subscribed, spotlighting a debt-free investment ethos and a rock-solid logistics site in Anchorage, Alaska. Strategic Facility Anchoring Investment...
Continue Reading
Top 5 Most Recently Viewed Articles
Eli Lilly's Leadership Expansion Aims for Future Growth Eli Lilly and Company (NYSE: LLY) has recently announced the strategic appointment of two new Executive Committee members and a significant expansion of leadership roles within the organization. This move is designed to accelerate the company's ambitious development pipeline, create new portfolio opportunities, and...
Continue Reading
LifeWallet, known for its Medicare claims recovery, took a swing in October 2024 by locking down an agreement with Hazel Partners Holdings LLC to grab recovery rights linked to over 450,000 Medicare members. Total claims? A jaw-dropping $10.6 billion. Traders' ears perked up when they caught wind of that figure—big numbers often mean big moves on the floor. This deal...
Continue Reading
Macerich Schedules Earnings Release and Call for Q3 2025 Macerich, a prominent real estate investment trust (REIT), has exciting news for investors as they prepare to announce their third quarter earnings for 2025. This announcement is set to take place shortly after the market closes on an upcoming Tuesday in early November. Details Surrounding the Earnings Conference...
Continue Reading
See's Candies Celebrates a Milestone with New Products See's Candies, an iconic chocolatier known for its delightful confections, is celebrating its 105th anniversary this year. To mark this special occasion, they are introducing a limited-edition treat called the Milk Scotchmallow. This new candy is designed to offer a smooth twist on one of their most beloved flavors,...
Continue Reading
Investigating Claims on Behalf of Skyworks Solutions Investors Pomerantz LLP has taken on the important task of investigating claims related to Skyworks Solutions, Inc. (NASDAQ: SWKS). This inquiry aims to safeguard the interests of investors who may have been affected by recent developments within the company. If you believe that you have a stake in this investigation,...
Continue Reading